Valve-related complications after mechanical heart valve implantation

Yoshio Misawa1

  • 1Division of Cardiovascular Surgery, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan. tcvmisa@jichi.ac.jp.

Surgery Today
|December 19, 2014
PubMed

Insights

Heart valve surgery survival rates are improving, but patients face risks from complications like thromboembolisms and endocarditis. Long-term monitoring is crucial for managing these valve-related issues.

Area of Science:

  • Cardiovascular Surgery
  • Biomedical Engineering
  • Clinical Outcomes Research

Background:

  • Heart valve surgeries are increasing globally, with significant patient numbers undergoing these procedures.
  • While early mortality rates have stabilized, long-term survival rates, exceeding 60% at 10 years, highlight the growing population of survivors.
  • The long-term management of patients post-valve surgery necessitates understanding and addressing potential complications.

Purpose of the Study:

  • To review and synthesize data on the incidence and types of valve-related complications following heart valve surgery.
  • To provide an overview of the rates of specific complications, including thromboembolisms, bleeding, endocarditis, and prosthetic valve dysfunction.
  • To identify areas requiring further research and clinical attention for improved patient outcomes.

Main Methods:

  • A comprehensive review of studies published after the year 2000 focusing on heart valve surgery complications.
  • Analysis of reported complication rates per patient-year for various adverse events.
  • Synthesis of data regarding the frequency of thromboembolisms, bleeding, endocarditis, and prosthetic valve dysfunctions.

Main Results:

  • The overall rate of valve-related complications ranges from 0.7% to 3.5% per patient-year.
  • Thromboembolisms occur at approximately 1% per patient-year, and bleeding complications at nearly 0.5% per patient-year.
  • Prosthetic valve endocarditis occurs at 0.5% per patient-year, associated with poor survival, while nonstructural dysfunction rates are 0.4%-1.2% per patient-year.

Conclusions:

  • Despite improved survival, patients require lifelong monitoring for valve-related complications, particularly those associated with anticoagulant therapy.
  • Thromboembolic and bleeding events remain significant concerns, necessitating careful management.
  • While structural valve dysfunction has decreased, nonstructural issues like paravalvular leaks and pannus ingrowth require ongoing attention and resolution.

Related Concept Videos

Heart Valves01:16

Heart Valves

The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
16.9K
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.2K
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
1.5K
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
396
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
560
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
562